Therapeutic Goods Order No. 94 (Standard for Haematopoietic Progenitor Cells derived from Cord Blood) 2017 (Cth)

Therapeutic Goods Order No. 94 (Standard for Haematopoietic Progenitor Cells derived from Cord Blood) 2017 Therapeutic Goods Act 1989

I, LARRY KELLY, a delegate of the Minister for Health for the purposes of subsection 10(1) of the Therapeutic Goods Act 1989, make the following order.

Dated 26 September 2017

(Signed by)

LARRY KELLY

Delegate of the Minister for Health

1 Name of order This order is the Therapeutic Goods Order No. 94 (Standard for Haematopoietic Progenitor Cells derived from Cord Blood) 2017. 2 Commencement (1) Each provision of this order specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this order 30 September 2017

Note: This table relates only to the provisions of this order as originally made. It will not be amended to deal with any later amendments of this order. (2) Any information in column 3 of the table is not part of this order. Information may be inserted in this column, or information in it may be edited, in any published version of this order. 3 Authority This order is made under subsection 10(1) of the Therapeutic Goods Act 1989. 4 Interpretation In this order:

Act means the Therapeutic Goods Act 1989.

cord blood means the blood remaining in the human placenta and umbilical cord after the umbilical cord has been clamped.

NetCord-FACT International Standards means the document titled NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration, Sixth Edition, published by NetCord and the Foundation for the Accreditation of Cellular Therapy in July 2016, as in force at that time.